13F holdings as of 2026-03-31 · vs 2025-12-31 · long US-listed positions only
| # | Holding | Shares | Value | % of 13F | QoQ Δ | |
|---|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 17.2M | $1.77B | 20.8% | +$32.1M | |
| 2 | BKD 3.5 10/15/29BROOKDALE SR LIVING INC | 306.9M | $505.4M | 6.0% | +$77.9M | |
| 3 | COGTCOGENT BIOSCIENCES INC | 9.0M | $348.1M | 4.1% | +$26.9M | |
| 4 | PRAXPRAXIS PRECISION MEDICINES I | ADD | 963K | $310.4M | 3.7% | +$44.1M |
| 5 | VTRSVIATRIS INC | 20.2M | $273.0M | 3.2% | +$21.4M | |
| 6 | UTHRUNITED THERAPEUTICS CORP DEL | ADD | 457K | $271.0M | 3.2% | +$63.4M |
| 7 | RVMDREVOLUTION MEDICINES INC | TRIM | 2.3M | $223.4M | 2.6% | -$7.2M |
| 8 | MIRM 4 05/01/29MIRUM PHARMACEUTICALS INC | 70.0M | $209.4M | 2.5% | +$28.7M | |
| 9 | ARWR 0 01/15/32ARROWHEAD PHARMACEUTICALS IN | NEW | 200.0M | $207.2M | 2.4% | new |
| 10 | CELCCELCUITY INC | 1.7M | $195.6M | 2.3% | +$24.7M | |
| 11 | CNCCENTENE CORP DEL | TRIM | 5.9M | $193.7M | 2.3% | -$71.6M |
| 12 | LRMRLARIMAR THERAPEUTICS INC | ADD | 35.6M | $160.2M | 1.9% | +$43.6M |
| 13 | BKDBROOKDALE SR LIVING INC | 11.6M | $159.2M | 1.9% | +$33.6M | |
| 14 | VERAVERA THERAPEUTICS INC | TRIM | 3.7M | $149.7M | 1.8% | -$55.8M |
| 15 | IONSIONIS PHARMACEUTICALS INC | 2.0M | $148.7M | 1.8% | -$8.0M | |
| 16 | BCRXBIOCRYST PHARMACEUTICALS INC | ADD | 15.0M | $143.2M | 1.7% | +$31.3M |
| 17 | INSPINSPIRE MED SYS INC | ADD | 2.7M | $139.4M | 1.6% | +$546K |
| 18 | LEGNLEGEND BIOTECH CORP | ADD | 7.7M | $139.1M | 1.6% | +$10.1M |
| 19 | AHCOADAPTHEALTH CORP | 11.5M | $136.6M | 1.6% | +$22.3M | |
| 20 | NEWAMSTERDAM PHARMA COMPANY | ADD | 4.3M | $136.5M | 1.6% | -$9.6M |
| 21 | ACHCACADIA HEALTHCARE COMPANY IN | 4.5M | $105.7M | 1.2% | +$41.6M | |
| 22 | ARWRARROWHEAD PHARMACEUTICALS IN | TRIM | 1.6M | $98.6M | 1.2% | -$23.0M |
| 23 | CPRXCATALYST PHARMACEUTICALS INC | TRIM | 3.9M | $97.6M | 1.2% | -$17.0M |
| 24 | INDVINDIVIOR PHARMACEUTICALS INC | NEW | 3.1M | $94.4M | 1.1% | new |
| 25 | XENEXENON PHARMACEUTICALS INC | ADD | 1.6M | $94.0M | 1.1% | +$69.7M |
| 26 | IONS 1.75 06/15/28IONIS PHARMACEUTICALS INC | 60.0M | $90.6M | 1.1% | -$4.7M | |
| 27 | PHARVARIS N V | 3.1M | $88.3M | 1.0% | +$1.6M | |
| 28 | SNDXSYNDAX PHARMACEUTICALS INC | NEW | 3.8M | $88.3M | 1.0% | new |
| 29 | TNGXTANGO THERAPEUTICS INC | ADD | 4.1M | $86.8M | 1.0% | +$61.0M |
| 30 | ALHC 4.25 11/15/29ALIGNMENT HEALTHCARE INC | 61.0M | $85.9M | 1.0% | -$6.7M | |
| 31 | DNTHDIANTHUS THERAPEUTICS INC | NEW | 1.0M | $85.6M | 1.0% | new |
| 32 | PFEPFIZER INC | NEW | 3.0M | $85.4M | 1.0% | new |
| 33 | NBIXNEUROCRINE BIOSCIENCES INC | TRIM | 610K | $80.4M | 0.9% | -$87.6M |
| 34 | DAWNGBXDAY ONE BIOPHARMACEUTICALS I | 3.7M | $79.8M | 0.9% | +$45.1M | |
| 35 | SVRASAVARA INC | 13.6M | $74.1M | 0.9% | -$7.7M | |
| 36 | ZBIO 2.5 04/01/32ZENAS BIOPHARMA INC | NEW | 65.0M | $67.3M | 0.8% | new |
| 37 | EHABUSDENHABIT INC | 4.7M | $66.9M | 0.8% | +$23.1M | |
| 38 | NEO 0.25 01/15/28NEOGENOMICS INC | 72.7M | $66.7M | 0.8% | +$2.0M | |
| 39 | GMABGENMAB A/S | NEW | 2.5M | $66.1M | 0.8% | new |
| 40 | BIOBIO RAD LABS INC | 226K | $63.0M | 0.7% | -$5.5M | |
| 41 | LNTHLANTHEUS HLDGS INC | 828K | $62.8M | 0.7% | +$7.7M | |
| 42 | SPRYARS PHARMACEUTICALS INC | 7.5M | $60.3M | 0.7% | -$27.2M | |
| 43 | STOKSTOKE THERAPEUTICS INC | 1.8M | $59.4M | 0.7% | +$1.5M | |
| 44 | NVSTENVISTA HOLDINGS CORPORATION | TRIM | 2.2M | $56.1M | 0.7% | +$6.6M |
| 45 | IDYAIDEAYA BIOSCIENCES INC | TRIM | 1.5M | $51.0M | 0.6% | -$23.5M |
| 46 | BLTEBELITE BIO INC | ADD | 304K | $48.5M | 0.6% | +$11.1M |
| 47 | BMRNBIOMARIN PHARMACEUTICAL INC | NEW | 852K | $48.1M | 0.6% | new |
| 48 | KYMRKYMERA THERAPEUTICS INC | 561K | $46.7M | 0.6% | +$3.1M | |
| 49 | CERTCERTARA INC | 7.8M | $44.5M | 0.5% | -$24.3M | |
| 50 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 4.9M | $43.7M | 0.5% | -$17.4M | |
| 51 | IRONDISC MEDICINE INC | ADD | 657K | $42.0M | 0.5% | +$1.4M |
| 52 | LIVN 2.5 03/15/29LIVANOVA PLC | 34.3M | $40.0M | 0.5% | +$308K | |
| 53 | SIONSIONNA THERAPEUTICS INC | 971K | $38.9M | 0.5% | -$1.0M | |
| 54 | CDNACAREDX INC | 2.2M | $38.0M | 0.4% | -$3.2M | |
| 55 | GPCRSTRUCTURE THERAPEUTICS INC | 768K | $37.0M | 0.4% | -$16.4M | |
| 56 | IMCR 2.5 02/01/30IMMUNOCORE HLDGS PLC | 30.0M | $27.0M | 0.3% | -$57K | |
| 57 | VCYTVERACYTE INC | 726K | $23.4M | 0.3% | -$7.2M | |
| 58 | ALNYALNYLAM PHARMACEUTICALS INC | 68K | $22.5M | 0.3% | -$4.5M | |
| 59 | EMBCEMBECTA CORP | TRIM | 2.5M | $22.4M | 0.3% | -$10.3M |
| 60 | TYRATYRA BIOSCIENCES INC | NEW | 549K | $21.0M | 0.2% | new |
| 61 | FHTXFOGHORN THERAPEUTICS INC | ADD | 4.4M | $21.0M | 0.2% | +$1.3M |
| 62 | DRUGBRIGHT MINDS BIOSCIENCES INC | NEW | 283K | $20.7M | 0.2% | new |
| 63 | CMPXCOMPASS THERAPEUTICS INC | 3.6M | $19.1M | 0.2% | -$288K | |
| 64 | MNPRMONOPAR THERAPEUTICS INC | ADD | 324K | $17.7M | 0.2% | +$6.6M |
| 65 | KYTXKYVERNA THERAPEUTICS INC | 2.0M | $17.3M | 0.2% | -$1.5M | |
| 66 | SGPSPYGLASS PHARMA INC | NEW | 550K | $14.3M | 0.2% | new |
| 67 | BBNXBETA BIONICS INC | ADD | 1.3M | $13.3M | 0.2% | -$15.3M |
| 68 | TSHATAYSHA GENE THERAPIES INC | 2.7M | $12.2M | 0.1% | -$2.8M | |
| 69 | TOITHE ONCOLOGY INSTITUTE INC | 3.4M | $10.3M | 0.1% | -$1.6M | |
| 70 | CGEMCULLINAN THERAPEUTICS INC | 386K | $5.5M | 0.1% | +$1.5M | |
| 71 | ANNXANNEXON INC | 584K | $3.2M | 0.0% | +$304K | |
| 72 | ALECALECTOR INC | 1.1M | $2.3M | 0.0% | +$623K | |
| 73 | NEWAMSTERDAM PHARMA COMPANY | 93K | $1.9M | 0.0% | -$275K | |
| 74 | EWEDWARDS LIFESCIENCES CORP | 14K | $1.1M | 0.0% | -$71K | |
| 75 | PHGEBIOMX INC | ADD | 131K | $493K | 0.0% | +$247K |
| 76 | MANEVERADERMICS INC | NEW | 5K | $316K | 0.0% | new |
| 77 | HUMHUMANA INC | 917 | $159K | 0.0% | -$76K | |
| 78 | TOIIWTHE ONCOLOGY INSTITUTE INC | 1.3M | $55K | 0.0% | -$96K | |
| 79 | QSIAWQUANTUM SI INC | 333K | $36K | 0.0% | -$31K | |
| 80 | PMVPPMV PHARMACEUTICALS INC | 9K | $11K | 0.0% | -$88 | |
| 81 | SRZNWSURROZEN INC | 167K | $3K | 0.0% | -$666 | |
| 82 | MYGNMYRIAD GENETICS INC | 505 | $2K | 0.0% | -$833 |
Source: SEC Form 13F. Values are as-of 2026-03-31 (quarter-end), not live. Percentages are of reported 13F value, not the fund’s full AUM (13F excludes shorts, cash, bonds, most non-US holdings).